📰 Statement Regarding News
Page 5 - Statement Regarding News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statement Regarding. Real-time updates on events, politics, business and more.
April 3, 2024
Rare Earth Breaking News - Defense Metals (TSX-V: DEFN.V) (OTCQB: DFMTF) Appoints Guy de Selliers de Moranville to the Board of Directors
April 3, 2024
Ultra Lithium Inc. is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders . On March 4, 2024, the Company announced that effective February 29, 2024 it has been granted a voluntary... - Veroeffentlicht am 03.04.2024
March 27, 2024
On March 5, 2024, the Department of Justice ("DOJ"), the Federal Trade Commission ("FTC"), and Department of Health and Human Services ("HHS," together the "Agencies")...
March 27, 2024
The healthcare industry remains a focal point of President Biden's antitrust agenda.
March 26, 2024
Defence Therapeutics Inc. , a Canadian biotechnology company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce the successful testing of a...
March 26, 2024
EQS-News: Defence Therapeutics Inc. / Key word(s): Product LaunchDEFENCE’S SUCCESSFUL RESULTS ON ITS  ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE 26.03.2024 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. ____________...
March 12, 2024
2023 saw a significant uptick in antitrust scrutiny and enforcement, particularly in the healthcare space. After much rhetoric and a setback in challenging state Certificate of Public...
February 29, 2024
The Hackett Group, Inc. (HCKT.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock The Hackett Group, Inc. | Nasdaq: HCKT | Nasdaq
February 29, 2024
Generative AI and Other Technology Are Key to Improving HR Efficiency and Effectiveness ...
February 29, 2024
Defence Therapeutics Inc. , one of the leading Canadian biotechnology companies working in the field of immune-oncology, is pleased to announce the publication of a peer-reviewed study on the...